Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.intimp.2024.113994 | DOI Listing |
Int Immunopharmacol
January 2025
Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; State Key Laboratory of Transvascular Implantation Devices, China; Heart Regeneration and Repair Key Laboratory of Zhejiang province, China; Binjiang Institute of Zhejiang University, Hangzhou 310053, China. Electronic address:
Nat Neurosci
January 2025
HuidaGene Therapeutics Inc., Shanghai, China.
Duplication of methyl-CpG-binding protein 2 (MECP2) gene causes MECP2 duplication syndrome (MDS). To normalize the duplicated MECP2 in MDS, we developed a high-fidelity Cas13Y (hfCas13Y) system capable of targeting the MECP2 (hfCas13Y-gMECP2) messenger RNA for degradation and reducing protein levels in the brain of humanized MECP2 transgenic mice. Moreover, the intracerebroventricular adeno-associated virus (AAV) delivery of hfCas13Y-gMECP2 in newborn or adult MDS mice restored dysregulated gene expression and improved behavior deficits.
View Article and Find Full Text PDFStem Cell Res Ther
October 2024
Department of Anatomy, Histology and Embryology, Shanghai Medical School of Fudan University, 138 Yixueyuan Road, Shanghai, 200032, People's Republic of China.
Am J Pathol
November 2024
Department of Rheumatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address:
Growth differentiation factor 11 (GDF11) belongs to the transforming growth factor beta superfamily and participates in various pathophysiological processes. Initially, GDF11 was suggested to act as a rejuvenator by improving age-related phenotypes of the heart, brain, and skeletal muscle in aged mice. Recent studies demonstrate that GDF11 also serves as an adverse risk factor for human frailty and diseases.
View Article and Find Full Text PDFBrain Behav Immun
August 2024
Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen 518048, PR China. Electronic address:
Background: The cognitive decline associated with type 2 diabetes (T2D) is often attributed to compromised hippocampal neurogenesis and exacerbated neural inflammation. This study investigates the therapeutic potential of growth differentiation factor 11 (GDF11) in reversing these neurodegenerative processes in diabetic mice.
Result: We utilized a murine model of T2D and examined the effects of GDF11 on learning, memory, neurogenesis, and neuroinflammatory markers.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!